News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
699,619 Results
Type
Article (39727)
Company Profile (247)
Press Release (659645)
Multimedia
Podcasts (51)
Webinars (12)
Section
Business (204186)
Career Advice (2008)
Deals (35422)
Drug Delivery (95)
Drug Development (81049)
Employer Resources (172)
FDA (16186)
Job Trends (14863)
News (345217)
Policy (32541)
Tag
Academia (2554)
Accelerated approval (5)
Adcomms (20)
Allergies (86)
Alliances (49444)
ALS (93)
Alzheimer's disease (1380)
Antibody-drug conjugate (ADC) (130)
Approvals (16187)
Artificial intelligence (258)
Autoimmune disease (22)
Automation (16)
Bankruptcy (360)
Best Places to Work (11636)
BIOSECURE Act (19)
Biosimilars (106)
Biotechnology (175)
Bladder cancer (78)
Brain cancer (27)
Breast cancer (288)
Cancer (2302)
Cardiovascular disease (179)
Career advice (1677)
Career pathing (30)
CAR-T (153)
Cell therapy (432)
Cervical cancer (20)
Clinical research (66059)
Collaboration (848)
Company closure (2)
Compensation (555)
Complete response letters (19)
COVID-19 (2590)
CRISPR (41)
C-suite (250)
Cystic fibrosis (101)
Data (2288)
Decentralized trials (2)
Denatured (19)
Depression (44)
Diabetes (275)
Diagnostics (6377)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (101)
Drug shortages (25)
Duchenne muscular dystrophy (96)
Earnings (86891)
Editorial (37)
Employer branding (21)
Employer resources (146)
Events (112584)
Executive appointments (736)
FDA (17528)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (763)
Gene editing (109)
Generative AI (19)
Gene therapy (308)
GLP-1 (716)
Government (4424)
Grass and pollen (4)
Guidances (130)
Healthcare (18818)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (119)
Indications (29)
Infectious disease (2734)
Inflammatory bowel disease (143)
Inflation Reduction Act (8)
Influenza (52)
Intellectual property (97)
Interviews (312)
IPO (16521)
IRA (40)
Job creations (3633)
Job search strategy (1422)
Kidney cancer (10)
Labor market (42)
Layoffs (473)
Leadership (17)
Legal (7910)
Liver cancer (76)
Lung cancer (324)
Lymphoma (156)
Machine learning (8)
Management (58)
Manufacturing (321)
MASH (71)
Medical device (13381)
Medtech (13386)
Mergers & acquisitions (19466)
Metabolic disorders (700)
Multiple sclerosis (82)
NASH (16)
Neurodegenerative disease (91)
Neuropsychiatric disorders (27)
Neuroscience (1927)
NextGen: Class of 2025 (6512)
Non-profit (4480)
Now hiring (40)
Obesity (371)
Opinion (204)
Ovarian cancer (78)
Pain (91)
Pancreatic cancer (88)
Parkinson's disease (150)
Partnered (21)
Patents (241)
Patient recruitment (115)
Peanut (46)
People (57337)
Pharmaceutical (63)
Pharmacy benefit managers (19)
Phase I (20578)
Phase II (29097)
Phase III (21667)
Pipeline (1308)
Policy (145)
Postmarket research (2563)
Preclinical (8751)
Press Release (64)
Prostate cancer (107)
Psychedelics (30)
Radiopharmaceuticals (246)
Rare diseases (382)
Real estate (5907)
Recruiting (65)
Regulatory (22315)
Reports (47)
Research institute (2320)
Resumes & cover letters (349)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (70)
Series A (131)
Series B (87)
Service/supplier (11)
Sickle cell disease (52)
Special edition (15)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3579)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (47)
The Weekly (30)
Vaccines (697)
Venture capitalists (42)
Weight loss (236)
Women's health (35)
Worklife (16)
Date
Today (213)
Last 7 days (899)
Last 30 days (3010)
Last 365 days (32586)
2025 (11506)
2024 (35220)
2023 (40076)
2022 (51173)
2021 (55714)
2020 (54083)
2019 (46539)
2018 (35019)
2017 (32110)
2016 (31480)
2015 (37554)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (718)
Alabama (53)
Alaska (7)
Arizona (233)
Arkansas (13)
Asia (37871)
Australia (6190)
California (6321)
Canada (2049)
China (532)
Colorado (271)
Connecticut (277)
Delaware (156)
Europe (81359)
Florida (938)
Georgia (211)
Idaho (57)
Illinois (545)
India (25)
Indiana (318)
Iowa (11)
Japan (170)
Kansas (105)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (913)
Massachusetts (4696)
Michigan (223)
Minnesota (398)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (67)
New Hampshire (63)
New Jersey (1773)
New Mexico (28)
New York (1783)
North Carolina (982)
North Dakota (8)
Northern California (2778)
Ohio (208)
Oklahoma (14)
Oregon (34)
Pennsylvania (1412)
Puerto Rico (13)
Rhode Island (33)
South America (1097)
South Carolina (25)
South Dakota (1)
Southern California (2378)
Tennessee (104)
Texas (940)
United States (23724)
Utah (187)
Virginia (151)
Washington D.C. (64)
Washington State (559)
West Virginia (3)
Wisconsin (56)
699,619 Results for "agenus inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Collaboration
Incyte Backs Out of Immuno-Oncology Pact With Agenus
The partnership dates back to 2015, when Incyte paid $60 million upfront for access to four checkpoint programs, including TIM-3, LAG-3, OX40 and GITR.
February 12, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Agenus Announces Botensilimab and Balstilimab Presentations at ASCO 2025
April 23, 2025
·
4 min read
Press Releases
Agenus to Provide Corporate Update and First Quarter 2025 Financial Report
April 29, 2025
·
2 min read
Press Releases
Agenus’ BOT/BAL Data in Pretreated Liver Cancer Presented at AACR 2025
April 25, 2025
·
5 min read
Press Releases
Agenus’ BOT/BAL Neoadjuvant Pan-Cancer Data from the NEOASIS Study Presented in an Oral Session at AACR
April 28, 2025
·
5 min read
Press Releases
Agenus to Present New BOT/BAL Data in Two Presentations at AACR 2025
March 25, 2025
·
4 min read
Press Releases
Agenus Unveils Colorectal Cancer Survey Findings, Highlighting the Urgent Need for Treatment Innovation
March 19, 2025
·
5 min read
Business
Agenus Announces Appointment of Dr. Jennifer Buell to Its Board of Directors
Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in developing novel immunological agents to treat various cancers, is pleased to announce the appointment of Dr. Jennifer Buell to its Board of Directors, on June 11, 2024, effective immediately.
June 17, 2024
·
4 min read
Press Releases
Agenus to Participate in B. Riley Securities Precision Oncology & Radiopharma Investor Conference
February 25, 2025
·
1 min read
Press Releases
Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2024 Financial Report
February 26, 2025
·
2 min read
1 of 69,962
Next
